These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35820511)

  • 1. Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.
    Abdoli M; Shafaati M; Ghamsari LK; Abdoli A
    Virus Res; 2022 Oct; 319():198857. PubMed ID: 35820511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination.
    Hossain MG; Tang YD; Akter S; Zheng C
    J Med Virol; 2022 May; 94(5):1815-1820. PubMed ID: 34936124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals.
    Ye ZW; Ong CP; Tang K; Fan Y; Luo C; Zhou R; Luo P; Cheng Y; Gray VS; Wang P; Chu H; Chan JF; To KK; Chen H; Chen Z; Yuen KY; Ling GS; Yuan S; Jin DY
    Cell Mol Immunol; 2022 May; 19(5):588-601. PubMed ID: 35352010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Wang Y; Yang C; Song Y; Coleman JR; Stawowczyk M; Tafrova J; Tasker S; Boltz D; Baker R; Garcia L; Seale O; Kushnir A; Wimmer E; Mueller S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34193524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
    van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
    Front Immunol; 2021; 12():781280. PubMed ID: 34987509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine.
    Xu J; Liu M; Niu X; Hanson J; Jung K; Ru P; Tu H; Jones DM; Vlasova AN; Saif LJ; Wang Q
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.
    Minami S; Kotaki T; Sakai Y; Okamura S; Torii S; Ono C; Motooka D; Hamajima R; Nouda R; Nurdin JA; Yamasaki M; Kanai Y; Ebina H; Maeda Y; Okamoto T; Tachibana T; Matsuura Y; Kobayashi T
    Microbiol Spectr; 2024 Apr; 12(4):e0285923. PubMed ID: 38415690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
    Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS
    Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.
    de Swart RL; de Leeuw OS; Oreshkova N; Gerhards NM; Albulescu IC; Vreman S; Gonzales JL; Maas R; van Kuppeveld FJM; Soema P; Bosch BJ; Peeters BPH
    Vaccine; 2022 Aug; 40(33):4676-4681. PubMed ID: 35820941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection.
    Lin JJ; Tien CF; Kuo YP; Lin EJ; Tsai WH; Chen MY; Tsai PJ; Su YW; Pathak N; Yang JM; Yu CY; Chuang ZS; Wu HC; Tsai WT; Dai SS; Liao HC; Chai KM; Su YS; Chuang TH; Liu SJ; Chen HW; Dou HY; Chen FJ; Chen CT; Liao CL; Yu GY
    Front Immunol; 2022; 13():872047. PubMed ID: 35585971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters.
    Deng S; Liu Y; Tam RC; Chen P; Zhang AJ; Mok BW; Long T; Kukic A; Zhou R; Xu H; Song W; Chan JF; To KK; Chen Z; Yuen KY; Wang P; Chen H
    Nat Commun; 2023 Apr; 14(1):2081. PubMed ID: 37045873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-transmissible live attenuated SARS-CoV-2 vaccine.
    Adler JM; Martin Vidal R; Voß A; Kunder S; Nascimento M; Abdelgawad A; Langner C; Vladimirova D; Osterrieder N; Gruber AD; Kunec D; Trimpert J
    Mol Ther; 2023 Aug; 31(8):2391-2407. PubMed ID: 37263272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.
    Muñoz-Alía MÁ; Nace RA; Balakrishnan B; Zhang L; Packiriswamy N; Singh G; Warang P; Mena I; Narjari R; Vandergaast R; Peng K-W; García-Sastre A; Schotsaert M; Russell SJ
    mBio; 2024 Feb; 15(2):e0292823. PubMed ID: 38193729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
    J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
    Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK
    Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.